Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

Under the terms of the Exclusive License, Radiance will pay CSPC an upfront payment of $15 million, and up to $150 million in potential development and regulatory milestone payments and over $1 ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...

In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Holdings announced its plans to advance the development of its proprietary Antibody Drug Conjugate (ADC) platform ...